Lyka Labs Intrinsic Value
Lyka Labs (LYKALABS) median intrinsic value is ₹51.11 from 3 valuation models (range ₹30–₹64), vs current price ₹73.95 — -30.9% downside (Trading Above Calculated Value), margin of safety -44.7%. For current market price and key ratios, visit Lyka Labs screener.
LYKALABS Valuation Methods Summary — DCF, Graham Number & P/E
Lyka Labs intrinsic value across 3 models vs current price ₹73.95 — upside/downside and value range per method. Analyse Lyka Labs shareholding analysis to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹51.11 | ₹46.00 - ₹56.22 | -30.9% | Book Value/Share: ₹25.56, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹64.44 | ₹58.00 - ₹70.88 | -12.9% | Revenue/Share: ₹32.22, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹29.58 | ₹23.66 - ₹35.50 | -60.0% | CF Growth: 5.0%, Discount: 15% |
LYKALABS Intrinsic Value vs Market Price — All Valuation Models
Lyka Labs fair value range ₹30–₹64 vs current market price ₹73.95 across 3 valuation models. Read Lyka Labs dividend policy for the complete payout history and dividend yield track record.
LYKALABS Intrinsic Value Analysis — Undervalued or Overvalued?
Lyka Labs median intrinsic value ₹51.11, current price ₹73.95 — Trading Above Calculated Value by 30.9%, margin of safety -44.7%.
What is the intrinsic value of LYKALABS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Lyka Labs (LYKALABS) is ₹51.11 (median value). With the current market price of ₹73.95, this represents a -30.9% variance from our estimated fair value.
The valuation range spans from ₹29.58 to ₹64.44, indicating ₹29.58 - ₹64.44.
Is LYKALABS undervalued or overvalued?
Based on our multi-method analysis, Lyka Labs (LYKALABS) appears to be trading above calculated value by approximately 30.9%.
LYKALABS Financial Health — Key Ratios vs Industry Benchmarks
Lyka Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.10 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -34.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -23.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
LYKALABS Cash Flow Quality — Operating & Free Cash Flow
Lyka Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹-4 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹2 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹79 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |